1. Home
  2. LNN vs IVA Comparison

LNN vs IVA Comparison

Compare LNN & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$109.07

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.09

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
IVA
Founded
1954
2011
Country
United States
France
Employees
N/A
77
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
LNN
IVA
Price
$109.07
$5.09
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$113.00
$16.20
AVG Volume (30 Days)
153.4K
230.6K
Earning Date
04-02-2026
03-30-2026
Dividend Yield
1.35%
N/A
EPS Growth
12.81
N/A
EPS
2.70
N/A
Revenue
$676,368,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.74
$751.20
P/E Ratio
$40.49
N/A
Revenue Growth
11.41
N/A
52 Week Low
$97.27
$2.94
52 Week High
$149.56
$7.98

Technical Indicators

Market Signals
Indicator
LNN
IVA
Relative Strength Index (RSI) 47.47 43.70
Support Level $106.63 $4.98
Resistance Level $115.75 $6.42
Average True Range (ATR) 3.43 0.26
MACD 0.28 -0.02
Stochastic Oscillator 45.63 25.00

Price Performance

Historical Comparison
LNN
IVA

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: